Xeloda Oral Tablet 150Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Xeloda: Oral tablet (150mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_599.JPG
Xeloda 150mg Tab
Roche Pharmaceuticals
Pill Identification: XELODA  |  150

What is this Medicine?

CAPECITABINE (ka pe SITE a been) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat breast cancer, and also colon or rectal cancer.

CVS Pharmacy Patient Statistics for Xeloda: Oral tablet(150mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Xeloda 150mg Tablet

NDC: 000041100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer, Colorectal Cancer

Sometimes used for but not FDA approved for the following conditions:
Biliary Tract Cancer, Gastric Cancer, Ovarian Cancer

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Xeloda 150mg Tablet
Drug Image file DrugItem_599.JPG
Roche Pharmaceuticals
Pill Identification: XELODA  |  150
Shape: oblong
Color: peach

Reported Side Effects for Xeloda 150mg Tablet

Hot Flashes Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Irritability Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Low Magnesium Levels Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<8.0%*
Severity: MILD
Onset: EARLY
Inflamed Eye Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Muscle Pain Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
<68.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Around The Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Dysarthria Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Excessive Thirst Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Difficulty Swallowing Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Conjunctivitis Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Hoarseness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<13.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<42.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<14.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
<33.0%*
Severity: MODERATE
Onset: DELAYED
Coughing Up Blood Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Skin Ulcer Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<9.6%*
Severity: SEVERE
Onset: DELAYED
Bone Pain Incidence:
0.1-8.0%*
Severity: MODERATE
Onset: DELAYED
Cholestasis Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Brain Attack Incidence:
0.1%*
Severity: SEVERE
Onset: EARLY
Coagulopathy Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Extra Abdominal Fluid Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Brain Dysfunction Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Pancytopenia Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Photosensitivity Incidence:
0.1%*
Severity: MILD
Onset: DELAYED
Liver Infection Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
0.1-13.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
0.1%*
Severity: MODERATE
Onset: RAPID
High Blood Pressure Incidence:
0.1%*
Severity: MODERATE
Onset: EARLY
Inflamed Heart Muscle Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
High Triglycerides Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Stomach Ulcer Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
0.1-7.0%*
Severity: MILD
Onset: DELAYED
Confusion Incidence:
0.1%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
0.2-7.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
0.2-6.0%*
Severity: MODERATE
Onset: EARLY
Yeast Infection Incidence:
0.2-7.0%*
Severity: MODERATE
Onset: DELAYED
Radiation Recall Reaction Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Blood Clot In Lung Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
0.2-1.2%*
Severity: MODERATE
Onset: RAPID
Intestinal Blockage Incidence:
0.3-6.0%*
Severity: SEVERE
Onset: DELAYED
Bowel Obstruction Incidence:
0.3-6.0%*
Severity: SEVERE
Onset: DELAYED
Throat Ulcers Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.4-27.5%*
Severity: MODERATE
Onset: DELAYED
Inflamed Intestine Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Migraine Incidence:
0.4%*
Severity: MODERATE
Onset: EARLY
Yellow Skin Incidence:
0.4%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
0.4%*
Severity: MODERATE
Onset: RAPID
Typhlitis Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
No White Blood Cells Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Incoordination Incidence:
0.5%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
0.8%*
Severity: MODERATE
Onset: DELAYED
Inflamed Vocal Cords Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: DELAYED
Bruises Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
High Calcium Levels Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
1.2%*
Severity: MILD
Onset: EARLY
Fluid Around The Lungs Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Throat Irritation Incidence:
2.0-12.0%*
Severity: MILD
Onset: EARLY
Low Calcium Levels Incidence:
2.3-48.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
3.9-22.8%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
4.0%*
Severity: MILD
Onset: RAPID
Hypoesthesia Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Eye Irritation Incidence:
5.0-15.0%*
Severity: MILD
Onset: RAPID
Onycholysis Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
5.0-48.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
5.0%*
Severity: MILD
Onset: RAPID
Headache Incidence:
5.0-15.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Nail Discoloration Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
6.0-41.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
6.0-14.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Intestinal Bleeding Incidence:
6.0%*
Severity: SEVERE
Onset: DELAYED
Nerve Pain Incidence:
6.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
6.0-12.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
7.0-28.0%*
Severity: MILD
Onset: EARLY
Skin Discoloration Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
7.0-9.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
7.0-35.0%*
Severity: MILD
Onset: EARLY
Tiredness Incidence:
7.0-10.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
7.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot Incidence:
8.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
8.0-15.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
9.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
9.0-26.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
10.0-26.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
10.0-12.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
12.0-21.0%*
Severity: MILD
Onset: DELAYED
Secretion Of Tears Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
15.0-37.0%*
Severity: MILD
Onset: EARLY
Low Lymphocytes Incidence:
15.0-48.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
16.0-42.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
22.0-67.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
24.0-37.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
34.0-53.0%*
Severity: MILD
Onset: EARLY
Low Blood Sodium Levels Incidence:
45.0%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
45.0%*
Severity: MODERATE
Onset: DELAYED
Hand And Foot Syndrome Incidence:
54.0-63.0%*
Severity: MODERATE
Onset: DELAYED
Low Albumin In Blood Incidence:
55.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Xeloda 150mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Food and Xeloda 150mg Tablet(Capecitabine)
Food and Capecitabine(Capecitabine)
Capecitabine should be taken with food.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Xeloda

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.